步长制药：步长（香港）累计质押公司股份约1.01亿股

Group 1 - The core point of the news is that the controlling shareholder of Buchang Pharma, Buchang (Hong Kong), holds approximately 491 million shares, accounting for 46.56% of the total share capital, and has pledged about 101 million shares, which is 20.56% of its holdings and 9.57% of the total share capital [1] - The total shares held by Buchang (Hong Kong) and its concerted parties amount to approximately 598 million shares, representing 56.72% of the total share capital, with a total of 101 million shares pledged, which is 16.87% of their holdings and 9.57% of the total share capital [1] - For the year 2024, the revenue composition of Buchang Pharma is 99.71% from the pharmaceutical industry and 0.29% from other businesses [1] Group 2 - As of the report, Buchang Pharma has a market capitalization of 18.6 billion yuan [2]